Search results

Measurement of factor X (FX or stuart factor) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FX deficient plasma is required

Measurement of Factor XI (FXI or factor rosenthal) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXI deficient plasma is required

Measurement of factor XI (FXI or factor rosenthal) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXI deficient plasma is required

Measurement of factor XII (FXII or factor hageman) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent).For any in vitro protocol or research study where a source of human FXII deficient plasma is required.

Measurement of factor XII (FXII or factor hageman) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXII deficient plasma is required.

For any in vitro protocol or research study where a source of human FXIII deficient plasma is required.

Control plasmas for quick and efficient measurement of the Global Fibrinolytic Capacity with Hyphen BioMed's lysis timer .

Test reagents for quick and efficient measurement of the Global Fibrinolytic Capacity with Hyphen BioMed's lysis timer .

Reagent with low phospholipid concentration for confirming the presence of lupus anticoagulants (LA). The presence of LA does not or only insignificantly prolong clotting time.

Reagent with low phospholipid concentration for lupus anticoagulants (LA) determination. The presence of LA prolongs clotting time.